Back to companies
CytomX Therapeutics, Inc.
CTMXUSNASDAQPharmaceuticals & HealthcareCytomX Therapeutics, Inc.
Revenue
$76.2mn
YoY -44.8%
Operating income
-$22.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API